Meritxell Balmaña

1.5k citations
21 papers · 1.1k indexed · 1 hit paper · h-index 16
Topics
Glycosylation and Glycoproteins Research (16 papers)Cancer Research and Treatments (6 papers)Galectins and Cancer Biology (6 papers)
Partner nations
PortugalAustriaSpain

In The Last Decade

Meritxell Balmaña

21 papers receiving 1.1k citations

Hit Papers

Glycosylation in the Era of Cancer-Targeted Therapy: Wher...20192026202120232019100200300

Peers

Meritxell Balmaña
Comparison fields: 5 of 76
  • Molecular Biology 903
  • Immunology 402
  • Oncology 172
  • Organic Chemistry 157
  • Cancer Research 137
Replace Stefan Mereiter with:
Stefan Mereiter Portugal
Diana Campos Portugal
Aurélie Cazet France
Keiko Miyazaki Japan
Nimali P. Withana United States
Richard Beatson United Kingdom
Hua‐Bei Guo United States
Stéphane Birklé France
Stefanie Mullins United States
Gianfranco Picco United Kingdom
Meritxell Balmaña relative to Stefan Mereiter Portugal Stefan Mereiter's profile →
Citations per field
00.5×
Stefan Mereiter · 1×
Citations per year

Countries citing papers authored by Meritxell Balmaña

Since Specialization
Citations

This map shows the geographic impact of Meritxell Balmaña's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meritxell Balmaña with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meritxell Balmaña more than expected).

Fields of papers citing papers by Meritxell Balmaña

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meritxell Balmaña. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meritxell Balmaña. The network helps show where Meritxell Balmaña may publish in the future.

Co-authorship network of co-authors of Meritxell Balmaña

This figure shows the co-authorship network connecting the top 25 collaborators of Meritxell Balmaña. A scholar is included among the top collaborators of Meritxell Balmaña based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meritxell Balmaña. Meritxell Balmaña is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 16
3 40
4 27
5 16
6 23
7 8
8 81
9
Glycosylation in the Era of Cancer-Targeted Therapy: Where Are We Heading?breakdown →
380
10 35
11 18
12 171
13 14
14 19
15 29
16 50
17 47
18 37
19 45
20 2

About Meritxell Balmaña

Meritxell Balmaña is a scholar working on Biotechnology, Biophysics and Molecular Biology, having authored 21 papers that have together received 1.1k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (16 papers), Cancer Research and Treatments (6 papers) and Galectins and Cancer Biology (6 papers). The work is most often cited by research in Immunology (402 citations), Molecular Biology (903 citations) and Cancer Research (137 citations). Meritxell Balmaña has collaborated with scholars based in Portugal, Austria and Spain. Frequent co-authors include Celso A. Reis, Stefan Mereiter, Joana Gomes, Diana Campos, Ana Magalhães, Juliana Poças, Catarina Gomes, Joana A. Macedo, Rosa Peracaula and Ângela Fernandes. Their work appears in journals such as The EMBO Journal, Cancer Cell and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026